16-09-2026 15:00 via wallstreet-online.de

Sunshine Biopharma Advances Lead Coronavirus Drug Candidate into IND-Enabling Studies

Nanomolar potency against PLpro with broad-spectrum SARS-CoV-2 variants activitySignificant dose-dependent suppression of pulmonary viral replication in vivoStrong oral bioavailability and preferential lung enrichment across multiple species FORT …
Weiterlesen »